东地中海地区 (EMR) 的儿科瘤学:当前状况和挑战
Arsalan Kabir Siddiqui1, Asim Fakhruddin Belgaumi1,2
1All authors have contributed to this manuscript and take responsibility for its contents.
Ecancermedicalscience
|March 5, 2024
概括
由于经济多样性,世卫组织东地中海地区的儿童癌症护理因经济多样性而异. 区域合作和倡议显示出改善平等获得优质儿科瘤服务的希望.
科学领域:
- 全球健康 全球健康
- 儿科瘤学 儿科瘤学
- 卫生系统研究 卫生系统研究
背景情况:
- 世卫组织东地中海地区 (EMR) 具有显著的经济多样性,影响了医疗保健系统的发展和儿童癌症护理的提供.
- 儿科瘤护理范围从一些国家的高度复杂的服务到EMR内的其他国家的不存在的提供.
- 报告的儿童癌症年龄标准化发病率 (100,000人中10.1人) 可能被低估,因为潜在的报名不足.
研究的目的:
- 评估世卫组织东地中海地区儿童癌症护理的现状.
- 确定改善儿科瘤服务和公平获取的挑战和机会.
- 突出区域合作的潜力和加强癌症护理能力的现有举措.
主要方法:
- 在EMR中,在不同经济环境中对医疗保健系统和儿童癌症护理的审查.
- 分析影响护理能力的因素,包括提供者培训,基础设施和财务可及性.
- 考察地缘政治不稳定和自然灾害对医疗保健服务的影响.
主要成果:
- 在EMR中,儿科瘤护理能力和获得能力存在显著差异,受国家收入水平的影响.
- 缺乏训练有素的医疗保健提供者普遍存在,特别是在低收入和中低收入国家,尽管正在出现培训计划.
- 高额的自费支出 (高达75%) 给低收入国家的家庭带来负担,慈善基金会和公共医院提供一些支持.
- 地缘政治动荡和自然灾害对几个地区国家的医疗保健能力产生了不利影响.
结论:
- 在EMR中,儿童癌症护理的实质性不平等仍然存在,需要有针对性的干预.
- 区域合作,教育支持和结合计划为能力建设和基础设施改善提供了可行的战略.
- 尽管面临挑战,但积极的变化是显而易见的,受到世卫组织儿童癌症全球倡议等倡议的推动,这表明了改善护理的上升轨迹.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


